It’s been three months since California voters overwhelmingly approved Proposition 36, a new law that pledged to provide ...
Mental health and substance abuse continues to be a serious concern in Florida. Data published last month in Forbes puts the ...
U.S.-based PleoPharma announced yesterday that the FDA has granted it a fast-track designation for PP-01, a new ...
Some 70 community mental health and substance abuse treatment providers gathered in Tallahassee to mark Behavioral Health Day ...
A new study (the first clinical trial of its kind) has shown that the GLP-1 agonist semaglutide — known by the brand name ...
healthday on MSN3d
Most People Worldwide Lack Good Treatment for Mental IllnessAbout 93% of people worldwide who struggle with mental health or substance abuse issues aren't getting adequate care, ...
For years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don ...
Stimulants affect the mind, brain, and body in several ways, many of which can be very positive, even in the long run. Find ...
The data, published in JAMA Psychiatry, add to the growing body of evidence supporting the use of GLP-1 receptor agonists for ...
The Involuntary Treatment Act provides for court-ordered mental health or substance abuse disorder treatment. It can be enacted when a person is deemed a danger to themselves, others or others ...
How did the proposed prison make it to 2025 and what are the common questions that continue to be addressed in various ...
The medications “help to bridge that gap between 'I want to get clean' and getting clean," a prisons official said.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback